Keyphrases
Gastrointestinal Malignancies
100%
Breast Cancer Genes
100%
Cancer Gene mutations
100%
Emerging Biomarkers
100%
PARP Inhibitor (PARPi)
66%
Breast Cancer
50%
Gastrointestinal Cancer
50%
Ovarian Cancer
16%
Tumor
16%
Prostate Cancer
16%
Clinical Data
16%
Targeted Therapy
16%
Genomic Instability
16%
Breast Cancer Treatment
16%
Pancreatic Cancer
16%
Clinical Practice
16%
Breast Cancer Susceptibility Gene 1 (BRCA1)
16%
Breast Cancer Risk
16%
Cancer-related
16%
DNA Repair Pathways
16%
DNA Damage
16%
Synthetic Lethality
16%
Predictive Value
16%
Preclinical Data
16%
Tumor Biology
16%
Cytotoxic Agents
16%
DNA Damage Repair
16%
Breast Cancer mutations
16%
Germline Genetic Testing
16%
Platinum-based Agents
16%
BRCAness
16%
Metastatic Pancreas Cancer
16%
Medicine and Dentistry
Biological Marker
100%
Breast Cancer
100%
Cancer
100%
Gene Mutation
100%
Tumor Gene
62%
Gastrointestinal Cancer
37%
Pancreas Cancer
25%
PARP Inhibitor
25%
DNA Repair
25%
Malignant Neoplasm
12%
Prostate Cancer
12%
Ovarian Cancer
12%
Neoplasm
12%
Targeted Therapy
12%
Lethality
12%
Genetic Screening
12%
Genomic Instability
12%
Tumor Biology
12%
Cytotoxic Agent
12%
Tumor-Related Gene
12%
Germ Cell
12%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Breast Cancer
100%
Digestive System Cancer
23%
Pancreas Cancer
15%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
15%
Neoplasm
15%
Malignant Neoplasm
7%
Prostate Cancer
7%
Ovary Cancer
7%
Cytotoxic Agent
7%
Lethality
7%